COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 77 filers reported holding COMPASS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,969,594 | -49.0% | 4,553,093 | -17.7% | 0.00% | 0.0% |
| Q2 2023 | $17,602,910 | -52.6% | 5,535,506 | -51.3% | 0.00% | -50.0% |
| Q1 2023 | $37,154,212 | +16.2% | 11,362,144 | +78.8% | 0.00% | -33.3% |
| Q4 2022 | $31,964,714 | +120.6% | 6,354,814 | 0.0% | 0.00% | +50.0% |
| Q3 2022 | $14,489,000 | -20.4% | 6,354,814 | -7.5% | 0.00% | 0.0% |
| Q2 2022 | $18,212,000 | +93.4% | 6,872,414 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $9,416,000 | -56.8% | 6,872,414 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $21,786,000 | – | 6,872,414 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,500,000 | $11,165,000 | 7.28% |
| Foresite Capital Management V, LLC | 4,400,000 | $13,948,000 | 3.43% |
| CHI Advisors LLC | 3,023,692 | $9,585,000 | 3.18% |
| Foresite Capital Opportunity Management V, LLC | 1,100,000 | $3,487,000 | 2.34% |
| Monashee Investment Management LLC | 2,000,000 | $6,340,000 | 1.57% |
| Orbimed Advisors | 21,642,975 | $68,608,000 | 0.88% |
| Rock Springs Capital Management LP | 5,328,088 | $16,890,000 | 0.39% |
| Vivo Capital, LLC | 2,000,000 | $6,340,000 | 0.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 700,000 | $2,219,000 | 0.24% |
| DAFNA Capital Management LLC | 196,091 | $622,000 | 0.16% |